CVS Health Co. (NYSE:CVS) Shares Acquired by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. boosted its position in shares of CVS Health Co. (NYSE:CVS - Free Report) by 5.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,918,949 shares of the pharmacy operator's stock after buying an additional 710,281 shares during the period. Charles Schwab Investment Management Inc. owned 1.03% of CVS Health worth $579,932,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the company. Van ECK Associates Corp boosted its holdings in shares of CVS Health by 17.2% during the 3rd quarter. Van ECK Associates Corp now owns 516,095 shares of the pharmacy operator's stock worth $32,452,000 after purchasing an additional 75,805 shares during the last quarter. National Pension Service boosted its holdings in shares of CVS Health by 17.4% during the 3rd quarter. National Pension Service now owns 2,843,402 shares of the pharmacy operator's stock worth $178,793,000 after purchasing an additional 421,416 shares during the last quarter. Asset Management One Co. Ltd. boosted its holdings in shares of CVS Health by 9.9% during the 3rd quarter. Asset Management One Co. Ltd. now owns 514,093 shares of the pharmacy operator's stock worth $32,326,000 after purchasing an additional 46,471 shares during the last quarter. PDS Planning Inc acquired a new position in shares of CVS Health during the 3rd quarter worth approximately $243,000. Finally, Hazlett Burt & Watson Inc. boosted its holdings in shares of CVS Health by 9.8% during the 3rd quarter. Hazlett Burt & Watson Inc. now owns 2,575 shares of the pharmacy operator's stock worth $163,000 after purchasing an additional 229 shares during the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Analyst Ratings Changes

CVS has been the topic of several recent research reports. JPMorgan Chase & Co. boosted their target price on CVS Health from $80.00 to $81.00 and gave the stock an "overweight" rating in a report on Tuesday, February 18th. Leerink Partnrs upgraded CVS Health from a "hold" rating to a "strong-buy" rating in a report on Wednesday, February 12th. Leerink Partners upgraded CVS Health from a "market perform" rating to an "outperform" rating and upped their price objective for the company from $55.00 to $75.00 in a report on Thursday, February 13th. TD Cowen upped their price objective on CVS Health from $73.00 to $80.00 and gave the company a "buy" rating in a report on Monday, November 25th. Finally, Truist Financial upped their price objective on CVS Health from $60.00 to $76.00 and gave the company a "buy" rating in a report on Thursday, February 13th. Four analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $69.83.

Insider Activity at CVS Health

In other CVS Health news, SVP James David Clark sold 7,513 shares of the firm's stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total transaction of $498,487.55. Following the transaction, the senior vice president now owns 8,394 shares of the company's stock, valued at approximately $556,941.90. This trade represents a 47.23 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Michael F. Mahoney acquired 30,000 shares of the company's stock in a transaction on Tuesday, February 18th. The shares were purchased at an average cost of $66.70 per share, for a total transaction of $2,001,000.00. Following the acquisition, the director now owns 39,356 shares of the company's stock, valued at approximately $2,625,045.20. The trade was a 320.65 % increase in their position. The disclosure for this purchase can be found here. 0.24% of the stock is currently owned by corporate insiders.

CVS Health Stock Up 1.7 %

Shares of CVS Health stock traded up $1.09 during trading hours on Friday, reaching $66.34. 10,082,148 shares of the company were exchanged, compared to its average volume of 11,965,158. CVS Health Co. has a 1 year low of $43.56 and a 1 year high of $80.75. The stock's fifty day moving average is $56.42 and its 200 day moving average is $56.76. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.60 and a current ratio of 0.81. The firm has a market cap of $83.64 billion, a PE ratio of 18.12, a PEG ratio of 0.98 and a beta of 0.54.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, topping analysts' consensus estimates of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. As a group, equities research analysts forecast that CVS Health Co. will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were issued a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 4.01%. The ex-dividend date of this dividend was Thursday, January 23rd. CVS Health's dividend payout ratio (DPR) is presently 72.68%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.